Moreover, HIF-2α is involved in lipid and amino acid metabolism in NAFLD, which may play a pivotal role in disease progression and be a major potential therapeutic target (49). The gene discussed is EPAS1; the disease is metabolic dysfunction-associated steatotic liver disease.